ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.

Abstract

UNLABELLED:

What's known on the subject? and What does the study add? Some evidence suggests that ABO blood type may be a risk factor for cancer incidence and prognosis. For example, a large study recently discovered an increased incidence of pancreatic cancer in patients with non-O blood type; however, it is not known whether blood group correlates with outcomes in patients with RCC. We found a significant and independent association between ABO blood group and overall survival in patients undergoing surgery for locoregional RCC. Specifically, we identified non-O blood type as a predictor of mortality.

OBJECTIVE:

• To determine whether ABO blood group is associated with survival after nephrectomy or partial nephrectomy for renal cell carcinoma (RCC).

PATIENTS AND METHODS:

• We conducted a retrospective cohort study of 900 patients who underwent surgery for locoregional RCC between 1997 and 2008 at a single institution. • Covariates included age, gender, race, American Society of Anesthesiology Physical Status, preoperative anaemia and hypoalbuminemia, tumour characteristics, lymph node status, procedure performed, transfusion status and ABO blood group. • Primary outcomes were overall (OS) and disease-specific survival (DSS). • Univariable survival analyses were performed using the Kaplan-Meier and log-rank methods. Multivariable analysis was performed using a Cox proportional hazards model.

RESULTS:

• The 3-year OS estimate was 75% (95%CI 70-79%) for O blood group and 68% (95% CI 63-73%) for non-O blood group (P= 0.072). The 3-year DSS was 81% (95% CI 76-85%) for O blood group and 76% (95%CI 71-80%) for non-O blood group (P= 0.053). • In the multivariable analysis for OS, non-O blood type was significantly associated with decreased OS (HR 1.68, 95%CI 1.18-2.39; P= 0.004) but not DSS (HR 1.53, 95%CI 0.97-2.41; P= 0.065).

CONCLUSION:

• These data suggest that ABO blood group is independently associated with OS in patients undergoing surgery for locoregional RCC. ABO blood group has not been previously recognized as a predictor of survival in RCC.

• Authors: Samuel D Kaffenberger, Todd M Morgan, Kelly L Stratton, Adu M Boachie, Daniel A Barocas, Sam S Chang, Michael S Cookson, S Duke Herrell, Joseph A Smith, Peter E Clark
• Journal: BJU international (BJU Int) Vol. 110 Issue 11 Pt B Pg. E641-6 (Dec 2012) ISSN: 1464-410X [Electronic] England
• PMID: 22958439 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural)
• Copyright: © 2012 BJU INTERNATIONAL.

Chemical References

• ABO Blood-Group System

Topics

• ABO Blood-Group System (blood)
• Aged
• Aged, 80 and over
• Carcinoma, Renal Cell (blood, mortality, surgery)
• Female
• Follow-Up Studies
• Humans
• Kaplan-Meier Estimate
• Kidney Neoplasms (blood, mortality, surgery)
• Male
• Middle Aged
• Nephrectomy
• Prognosis
• Proportional Hazards Models
• Retrospective Studies
• Risk Factors
• Survival Rate (trends)
• United States (epidemiology)